Book a demo
Skip to content

Stonewake Monitoring

Senti Biosciences files 8-K covering a debt obligation

Senti Biosciences Holdings, Inc. filed a Form 8-K on 2026-09-04 reporting entry into a debt obligation, days after receiving a delisting notice.

Export financeUSAPublished · 3 sourced facts

Senti Biosciences Holdings, Inc., a Delaware-incorporated biological products company listed on Nasdaq under the ticker SNTI, filed a Form 8-K with the SEC on 2026-09-04.[1][2]

The filing, which carries accession number 0001628280-26-060600 and covers a period ending 2026-09-03, includes Item 1.01, Item 2.03, and Item 9.01.[1]

The filing is categorized as a debt obligation event, and its matched document is snti-20260903.htm.[1]

Separately, the company received a delisting notice dated 2026-09-02.[3]

Sources

  1. [1]SEC EDGAR: 8-K, 0001628280-26-060600, 4 Sep 2026
  2. [2]SEC EDGAR: CIK 0001854270, Senti Biosciences Holdings, Inc.
  3. [3]SEC EDGAR

SEC EDGAR

← All briefs